姓名:羅錦河  Gin-Ho Lo    科別:胃腸肝膽科    論文篇數: 109


AuthorTitleSourceYear
Wang HW, Tsai PC, Chen CY, et al.Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study.Am J Cancer Res. 2022 Jul 15;12(7):3164-3174.2022
Gin-Ho Lo.Letter to the editor: Could COVID-19 vaccination reduce postinfection mortality in most patients with cirrhosis?Hepatology. 2022 Aug 24:10.1002/hep.32751. doi: 10.1002/hep.32751.2022
Chen CY, Chuang WL, Qin A, Zhang WH, Zhu LY, Zhang GQ, Chen JJ, Lo CC, Zhou X, Mao X, Shang J, Kuo HT, Xie W, Chen CH, Lo GH, Jun DW, Dang S, Tsai CY, Wang TF, Lai HH, Tseng KC, Huang YW, Chen PJ.A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C.JGH Open. 2022 Oct 10;6(11):782-791. doi: 10.1002/jgh3.12825.2022
Gin-Ho Lo.The Beauty and Sorrow of Using Proton Pump Inhibitors in Patients With Cirrhosis.Gastroenterology. 2022 Dec;163(6):1717-1718. doi: 10.1053/j.gastro.2022.07.063.2022
Liu CJ, Sheen IS, Chen CY, Chuang WL, Wang HY, Tseng KC, Chang TT, Yang J, Massetto B, Suri V, Camus G, Jiang D, Zhang F, Gaggar A, Hu TH, Hsu YC, Lo GH, Chu CJ, Chen JJ, Peng CY, Chien RN, Chen PJ.Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.Clin Infect Dis. 2022 Aug 31;75(3):453-459. doi: 10.1093/cid/ciab971.2022
Gin-Ho Lo.Reply to Singh et alEndoscopy. 2021 Feb;53(2):211. doi: 10.1055/a-1243-0660. Epub 2021 Jan 27.2021
Hsieh MH, Bair MJ, Tsai PC, et al.Long-term risk of end stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.J Gastroenterol Hepatol. 2021 Aug;36(8):2247-2254. doi: 10.1111/jgh.15469. Epub 2021 Mar 30.2021
Wei-Fan Hsu, Pei-Chien Tsai, Chi-Yi Chen, et al.Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (T-COACH).J Gastroenterol Hepatol. 2021 May 7. doi: 10.1111/jgh.15538. Epub ahead of print.2021
Chen YS, Hsieh PM, Lin HY, Hung CM, Lo GH, Hsu YC, Lu IC, Lee CY, Wu TC, Yeh JH, Hsiao P, Li YC, Wang YC, Hsieh KC, Lin CW.Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.BMC Gastroenterol. 2021 May 14;21(1):220. doi: 10.1186/s12876-021-01807-4.2021
Lin CW, Chen YS, Lo GH, Wu TC, Yeh JH, Yeh ML, Dai CY, Huang JF, Chuang WL, Roberts L, Jun DW, Toyoda H, Yasuda S, Nguyen MH, Yu ML.Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma.Hepatol Int. 2021 Aug;15(4):946-956. doi: 10.1007/s12072-021-10169-8. Epub 2021 May 18.2021
Yi-Shin Huang, Ting-Tsung Chang, Cheng-Yuan Peng, Gin-Ho Lo, Chao-Wei Hsu, Chi-Tan Hu, Yi-Hsiang Huang.Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury.Hepatol Int. 2021 Aug 11. Epub ahead of print.2021
Yeh ML, Hung CH, Tseng KC, et al.Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).Hepatol Int. 2021 Aug 7. Epub ahead of print.2021
Hsu WF, Tsai PC, Chen CY, et al.Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).J Gastroenterol Hepatol. 2021 Oct;36(10):2884-2892. doi: 10.1111/jgh.15538. Epub 2021 May 21.2021
Yi-Shin Huang, Chen-Yi Wu, Ting-Tsung Chang, Cheng-Yuan Peng, Gin-Ho Lo, Chao-Wei Hsu, Chi-Tan Hu, Yi-Hsiang Huang.Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.Liver Int. 2021 Nov;41(11):2671-2680. doi: 10.1111/liv.14990. Epub 2021 Jul 6.2021
Yi-Shin Huang, Shao-Yu Tseng, Wen-Wen Chen, Ting-Tsung Chang, Cheng-Yuan Peng, Gin-Ho Lo, Chao-Wei Hsu, Chi-Tan Hu, Yi-Hsiang Huang.Clinical characteristics and outcomes of drug-induced liver injury in Taiwan with an emphasis on the impact of chronic hepatitis B infection.J Chin Med Assoc. 2021 Oct 25. doi: 10.1097/JCMA.0000000000000648. Epub ahead of print.2021
Yuan-Chen Li, Ping-Hung Chen, Jen-Hao Yeh, Pojen Hsiao, Gin-Ho Lo, TaoQian Tan, Pin-Nan Cheng, Hung-Yu Lin, Yaw-Sen Chen, Kun-Chou Hsieh, Pei-Min Hsieh, Chih-Wen Lin.Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.BMC Gastroenterol. 2021 Nov 8;21(1):418. doi: 10.1186/s12876-021-01995-z.2021
Liu CJ, Sheen IS, Chen CY, Chuang WL, Wang HY, Tseng KC, Chang TT, Yang J, Massetto B, Suri V, Camus G, Jiang D, Zhang F, Gaggar A, Hu TH, Hsu YC, Lo GH, Chu CJ, Chen JJ, Peng CY, Chien RN, Chen PJ.Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up 108 Weeks Posttreatment.Clin Infect Dis. 2021 Dec 2:ciab971. doi: 10.1093/cid/ciab971.2021
Jen-Hao Yeh,Tsung-Chin Wu,Po-Jen Hsiao,Daw-Shyong Perng,Jen-Chieh Chen,Gin-Ho Lo,Chia-Chang Hsu,Chih-Wen Lin.A single-center retrospective study comparing 1-day and 3-day low-residue diets for bowel preparation.Adv Dig Med. 2022;1–8.DOI: 10.1002/aid2.133062021
Jen-Hao Yeh, Gin-Ho Lo, Ru-Yi Huang, Chih-Wen Lin, Wen-Lun Wang, Daw-Shyong Perng.Short-course vasoconstrictors are adequate for esophageal variceal bleeding after endoscopic variceal ligation: A systematic review and meta-analysis.Sci Prog. 2021 Jul-Sep;104(3):368504211031711. doi: 10.1177/00368504211031711.2021
Gin-Ho LoCould Variceal Screening Stratified by Liver/Spleen Stiffness Replace the Role of Endoscopy?.Hepatology. 2020;71(3):1133. doi:10.1002/hep.310042020
Lo GH.Letter to the Editor: Can Colder Weather and Fewer Sunlight Hours Truly Increase Alcohol Consumption and Alcoholic Cirrhosis?Hepatology. 2020;71(2):762. doi:10.1002/hep.308652020
Lo GH.Letter of Editor: Could variceal screening stratified by liver/spleen stiffness replace the role of endoscopy ?Hepatology. 2020;71(3):1133. doi:10.1002/hep.310042020
Gin-Ho Lo.Did direct-acting antiviral therapy for hepatitis C virus infection really improve the survival of patients with hepatocellular carcinoma ?Gastroenterology. 2020 May;158(6):1843-1844. doi: 10.1053/j.gastro.2020.01.019. Epub 2020 Jan 15.2020
Hsu WF, Chen CY, Tseng KC, et al.Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.Sci Rep. 2020;10(1):5372. Published 2020 Mar 25. doi:10.1038/s41598-020-61991-32020
Chih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, Yao-Chun Hsu , Chia-Chang Hsu, Tsung-Chin Wu, Jen-Hao Yeh, Pojen Hsiao, Pei-Min Hsieh, Hung-Yu Lin, Chih-Wen Shu, Chao-Ming Hung.Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.BMC Gastroenterol. 2020;20(1):99. Published 2020 Apr 10. doi:10.1186/s12876-020-01235-w2020
Gin-Ho Lo, Chih-Wen Lin, Chi-Ming Tai, Daw-Shyong Perng, I-Lin Chen, Jen-Hao Yeh, Hui-Chen Lin.A prospective, randomized trial of thrombin versus cyanoacrylate injection in the control of acute gastric variceal hemorrhage [published online ahead of print, 2020 Apr 14].Endoscopy. 2020;10.1055/a-1127-3170. doi:10.1055/a-1127-31702020
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, et al.Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.Sci Rep. 2020;10(1):5372. Published 2020 Mar 25. doi:10.1038/s41598-020-61991-32020
Hsu SJ, Yu ML, Su CW, Peng CY, Chien RN, Lin HH, Lo GH, Su WW, Kuo HT, Hsu CW, Yang SS, Yang SS, Tseng KC, Qin A, Huang YW, Chuang WLRopeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C.J Formos Med Assoc. 2020 Oct 16:S0929-6646(20)30459-9. doi: 10.1016/j.jfma.2020.09.018. Epub ahead of print. PMID: 33077341.2020
Gin-Ho Lo.Should we pursue high obliteration rate or high hemostatic rate in the therapy of gastric varices?Endoscopy. 2020 Aug;52(8):709. doi: 10.1055/a-1167-8274. Epub 2020 Jul 28. PMID: 32722839.2020
Tsai PC, Chen CY, Kuo HT, et al.Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH).Open Forum Infect Dis. 2020 Aug 31;7(10):ofaa397. doi: 10.1093/ofid/ofaa397.2020
Huang CF, Lai HC, Chen CY, et al.Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).Am J Gastroenterol. 2020 Aug;115(8):1226-1235. doi: 10.14309/ajg.0000000000000606.2020
Lo GH.The Use of Vasoconstrictors in Acute Variceal Bleeding: How Long Is Enough?Clin Endosc. 2019 Jan;52(1):36-39. doi: 10.5946/ce.2018.084. Epub 2019 Jan 22.2019
Lo GH.Preemptive TIPS must be the treatment of choice for Child-Pugh class C patients with variceal bleeding ?Hepatology. 2019 Mar 10. doi: 10.1002/hep.30608. [Epub ahead of print]2019
Hsu CC, Hsieh PM, Chen YS, Lo GH, Lin HY, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML, Lin CW.Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection.Cancer Med. 2019 May 16. doi: 10.1002/cam4.2229. [Epub ahead of print2019
Lo GH.Therapy of Hepatitis B: Is It Really Not Associated With Hepatitis B Surface Antigen Seroclearance ?Gastroenterology. 2019 Apr 11. pii: S0016-5085(19)35691-4. doi: 10.1053/j.gastro.2019.03.069. [Epub ahead of print]2019
Lo GH.The Transplantation of Fecal Microbiota for Cirrhotic Patients.Gastroenterology. 2019;157(3):902. doi:10.1053/j.gastro.2019.06.0402019
Hsiao P, Hsieh KC, Chen YS, Hsu CC, Lo GH, Li YC, Hsieh PM, Lin HY, Wu TC, Yeh JH, Lin CW.Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma.Medicine (Baltimore). 2019 Jun;98(25):e16074. doi: 10.1097/MD.0000000000016074.2019
Lo GH.Letter to the Editor: Preemptive TIPS Must Be the Treatment of Choice for Child-Pugh Class C Patients With Variceal Bleeding?Hepatology. 2019 Aug;70(2):752-753. doi: 10.1002/hep.30608.2019
Huang CF, Iio E, Jun DW, et al.Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium.Hepatol Int. 2019 Sep;13(5):587-598. doi: 10.1007/s12072-019-09974-z. Epub 2019 Aug 28.2019
Hui-Chen Lin, Gin-Ho Lo, Tao-Qian Tang.Could Antibiotic Prophylaxis in Cirrhotic Patients with Acute Variceal Bleeding Prevent Rebleeding?E-Da Medical Journal. 2019;6(2):17-24.2019
Lo GH.Letter to the Editor: Beta-blockers are preferable to banding ligation for primary prophylaxis of variceal bleeding?Hepatology. 2019;70(5):1876. doi:10.1002/hep.308562019
Lo GH.The use of steroid for transcatheter arterial chemoembolization: To relieve symptoms or to mask adverse events?Hepatology. 2018 Jun 14. doi: 10.1002/hep.30112. [Epub ahead of print]2018
Lo GH.Does antiplatelet therapy really reduce the risk of hepatocellular carcinoma in hepatitis B patients with antiviral drug?Hepatology. 2018 Apr;67(4):1642-1643. doi: 10.1002/hep.29794. Epub 2018 Feb 28.2018
Lo GH.Endoscopy Examination Time: Longer Is Really Better?Gastroenterology. 2018 Feb;154(3):765. doi: 10.1053/j.gastro.2017.09.056. Epub 2018 Jan 18.2018
Lo GH.Endoscopic treatments for portal hypertension.Hepatol Int. 2018 Feb;12(Suppl 1):91-101. doi: 10.1007/s12072-017-9828-8. Epub 2017 Nov 7.2018
Lo GH, Reiberger T.Peptic ulcer bleeding in patients with cirrhosis: Is it as bad as variceal bleeding?Hepatology. 2018 Apr;67(4):1219-1220. doi: 10.1002/hep.29680. Epub 2018 Feb 19.2018
Lin CW, Chen YS, Lin CC, Lee PH, Lo GH, Hsu CC, Hsieh PM, Koh KW, Chou TC, Dai CY, Huang JF, Chuang W8, Chen YL, Yu MLAutophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection.Clin Transl Gastroenterol. 2018 Jul 2;9(6):166. doi: 10.1038/s41424-018-0033-4.2018
Lin CW, Chen YS, Lin CC, Lee PH, Lo GH, Hsu CC, Hsieh PM, Koh KW, Bair MJ, Dai CY, Huang JF, Chuang WL, Chen YL, Yu ML.Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection.PLoS One. 2018 Sep 4;13(9):e0202650. doi: 10.1371/journal.pone.0202650. eCollection 2018.2018
Lo GH.The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.Gastroenterology. 2018 Apr;154(5):1551. doi: 10.1053/j.gastro.2017.12.041. Epub 2018 Mar 8.2018
Lo GH.Did Statins Really Improve Survival in Cirrhotic Patients With a History of Variceal Bleeding?Am J Gastroenterol. 2017 Feb;112(2):386-387. doi: 10.1038/ajg.2016.486.2017
Lee TY, Lin CC, Chen CY, Wang TE, Lo GH, Chang CS, Chao Y.Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.Medicine (Baltimore). 2017 Sep;96(37):e7655. doi: 10.1097/MD.0000000000007655.2017
Lo GH.Did Carvedilol Really Have More Severe Adverse Events than Propranolol in Cirrhotic Patients?Am J Gastroenterol. 2017 May;112(5):808. doi: 10.1038/ajg.2017.32017
Lo GH.The interval of endoscopic variceal ligation: The shorter the better?Hepatology. 2017 Apr;65(4):1414-1415. doi: 10.1002/hep.28903. Epub 2016 Dec 10.2017
Lo GH.The risk of bleeding after invasive procedures in patients with cirrhosis with severe coagulopathy.Hepatology. 2017 Feb;65(2):751. doi: 10.1002/hep.28855. No abstract available.2017
Lo GH.The use of esophageal stent in controlling acute refractory variceal bleeding.Hepatology. 2017 Jan;65(1):385-386. doi: 10.1002/hep.28750. Epub 2016 Aug 23.2017
Albillos A, Zamora J, Martínez J, Arroyo D, Ahmad I, De-la-Peña J, Garcia-Pagán JC, Lo GH, Sarin S, Sharma B, Abraldes J, Bosch J, Garcia-Tsao G; Baveno cooperation.Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.Hepatology. 2017 May 25. doi: 10.1002/hep.29267. [Epub ahead of print]2017
Lin HC, Lo GH, Perng DS, Lin CW.Compliance with guidelines of using vasoconstrictors in patients with acute esophageal variceal bleeding.E-Da M J. 2017;4(2):1-7.2017
Lo GH.Do we need vasoconstrictors up to 5 days after successful hemostasis by ligation of bleeding varices?Hepatology. 2017 Sep;66(3):1009. doi: 10.1002/hep.29322. Epub 2017 Jul 31.2017
Lin CW, Lin CC, Lee PH, Lo GH, Hsieh PM, Koh KW, Lee CY, Chen YL, Dai CY, Huang JF, Chuang WL, Chen YS, Yu ML.The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma.Oncotarget. 2017 Aug 1;8(54):91902-91913. doi: 10.18632/oncotarget.19763. eCollection 2017 Nov 3.2017
Liu CJ, Chuang WL, Sheen IS, Wang HY, Chen CY, Tseng KC, Chang TT, Massetto B, Yang JC, Yun C, Knox SJ, Osinusi A, Camus G, Jiang D, Brainard DM, McHutchison JG, Hu TH, Hsu YC, Lo GH, et al.Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV.Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36369-2. doi: 10.1053/j.gastro.2017.11.011. [Epub ahead of print]2017
Lo GH.The Use of Doppler Endoscopic Probe in Hemostasis of Nonvariceal Gastrointestinal Bleeding: To Increase Efficacy or to Increase Work Load?Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35884-5. doi: 10.1053/j.gastro.2017.06.060. [Epub ahead of print]2017
Lo GH.Does the Use of Doppler Endoscopic Probe in Hemostasis of Nonvariceal Gastrointestinal Bleeding Increase Efficacy or Work Load?Gastroenterology. 2017 Sep;153(3):868. doi: 10.1053/j.gastro.2017.06.060. Epub 2017 Aug 3.2017
Lo GH.Did Statins Really Improve Survival in Cirrhotic Patients With a History of Variceal Bleeding?Gastroenterology. 2016 Nov;151(5):1037. doi: 10.1053/j.gastro.2016.06.056. Epub 2016 Oct 1.2016
Lo GH.Endoscopic therapy plus beta blocker is still the first choice for prevention of variceal rebleeding?Hepatology. 2016 Nov;64(5):1816-1817. doi: 10.1002/hep.28665. Epub 2016 Jul 7.2016
Chuang WL, Chien RN, Peng CY, Chang TT, Lo GH, Sheen IS, Wang HY, Chen JJ, Yang JC, Knox SJ, Gao B, Garrison KL, Mo H, Pang PS, Hsu YC, Hu TH, Chu CJ, Kao JH.Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.J Gastroenterol Hepatol. 2016 Jul;31(7):1323-9. doi: 10.1111/jgh.13305.2016
Chiu HC, Hsieh HM, Lin YC, Kuo SJ, Kao HY, Yeh SJ, Chang WH, Hsiao PJ, Chen YS, Lin SL, Lo GH, Ker CG, Hung YH, Cheng HA, Chou TH, Chou SY, Wang JH, Wang CFPatient assessment of diabetes care in a pay-for-performance program.Int J Qual Health Care. 2016 Apr;28(2):183-90. doi: 10.1093/intqhc/mzv120. Epub 2016 Jan 26.2016
Hui-Chen Lin, Gin-Ho Lo, Daw-Shyong Perng, Chih-Wen Lin, Chi-Ming Tai.Compliance with antibiotic prophylaxis guidelines in patients with acute variceal bleeding.E-Da Med J. 2016;3(1):9-16.2016
Kao JH, Chien RN, Chang TT, Peng CY, Hu TH, Lo GH, Wang HY, Chen JJ, Yang JC, Knox SJ, Han L, Mo H, Mathias A, Brainard DM, Sheen IS, Hsu YC, Chu CJ, Chuang WLA phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.Liver Int. 2016 Aug;36(8):1101-7. doi: 10.1111/liv.13082. Epub 2016 Mar 23.2016
Lo GH.Is cryoablation really more effective than radiofrequency ablation in hepatocellular carcinoma?Hepatology. 2016 Jun;63(6):2061. doi: 10.1002/hep.28005. Epub 2015 Dec 14.2016
Lo GH.Was Adjuvant Immunotherapy Really Effective to Reduce Hepatocellular Carcinoma Recurrence?Gastroenterology. 2015 Nov;149(6):1639. doi: 10.1053/j.gastro.2015.07.069. Epub 2015 Oct 2.2015
Lo GH, Lin CW, Hsu YC.A controlled trial of early versus delayed feeding following ligation in the control of acute esophageal variceal bleedingJ Chin Med Assoc. 2015 Sep 1. pii: S1726-4901(15)00198-7. doi: 10.1016/j.jcma.2015.07.004. [Epub ahead of print]2015
Lo GH.The use of transarterial chemoembolization in hepatiocellular carcinoma 2 cm or smaller.Am J Gastroenterol. 2015 Jan;110(1):196. doi: 10.1038/ajg.2014.364.2015
Lin CW, Chen YS, Lin CC, Chen YJ, Lo GH, Lee PH, Kuo PL, Dai CY, Huang JF, Chung WL, Yu ML.Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy.Sci Rep. 2015 Oct 30;5:15807. doi: 10.1038/srep15807.2015
Lo GH.The optimal interval of endoscopic variceal ligation: an issue of controversy.Gastrointest Endosc. 2015 Mar;81(3):774. doi: 10.1016/j.gie.2014.09.007.2015
Hui-Chen Lin, Gin-Ho Lo, Daw-Shyong Perng, Chi-Yang Chang.A controlled trial of vasoconstrictor plus histoacryl injection versus proton pump inhibitor plus histoacryl injection in the management of acute gastric variceal bleeding.E-Da Med J. 2015;2(1):1-7.2015
Lo GH.Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with cirrhosis - Facts or Fiction ?Hepatology. 2014 Feb 12. doi: 10.1002/hep.27073. [Epub ahead of print]2014
Lo GH.Could post-interferon treatment α-fetoprotein levels truly predict hepatocarcinogenesis ?Hepatology. 2014 Aug;60(2):763. doi: 10.1002/hep.27065. Epub 2014 Jun 26.2014
Lo GH.Did postoperative peg-interferon plus ribavirin really reduce recurrence of hepatitis C virus-related hepatocellular carcinoma ?Hepatology. 2014 Apr;59(4):1652. doi: 10.1002/hep.26693. Epub 2014 Feb 25.2014
Lo GH.Lack of difference among vasoconstrictors: Similar effectiveness or similar ineffectiveness?Hepatology. 2015 Aug;62(2):653. doi: 10.1002/hep.27648. Epub 2015 May 28.2014
Lo GH.Does long-term entecavir treatment really reduce hepatocellular carcinoma incidence in patients with hepatitis B virus infection?Hepatology. 2014 May;59(5):2053. doi: 10.1002/hep.26773. Epub 2014 Mar 24.2014
Lo GH.Controlled trial of TIPS versus cyanoacrylate glue for gastric variceal bleeding.Gastrointest Endosc. 2014 Jan;79(1):182. doi: 10.1016/j.gie.2013.08.011.2014
Lo GH.Higher viral load, higher hepatitis B surface antigen clearance?Hepatology. 2014 Jun;59(6):2427. doi: 10.1002/hep.26900. Epub 2014 Apr 14.2014
Lo GH.The use of transjugular intrahepatic portosystemic stent shunt (TIPS) in the management of portal hypertensive bleeding.J Chin Med Assoc. 2014 Aug;77(8):395-402. doi: 10.1016/j.jcma.2014.05.010. Epub 2014 Jul 12.2014
Lo GH.The Use of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase.Gastroenterology. 2014 Sep;147(3):718-9. doi: 10.1053/j.gastro.2014.06.042. Epub 2014 Jul 27.2014
Lo GH.The use of AFP-based algorithm to predict hepatocellular carcinoma.Gastroenterology. 2014 Sep;147(3):718. doi: 10.1053/j.gastro.2014.05.047. Epub 2014 Jul 27.2014
Wang HM, Lo GH, Chen WC, Chan HH, Tsai WL, Yu HC, Tsay FW, Hsu PI.Randomized controlled trial of monthly versus biweekly endoscopic variceal ligation for the prevention of esophageal variceal rebleeding.J Gastroenterol Hepatol. 2014 Jun;29(6):1229-36.2014
Hsu YC, Wu CY, Lane HY, Chang CY, Tai CM, Tseng CH, Lo GH, Perng DS, Lin JT, Mo LR.Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B.J Antimicrob Chemother. 2014 Jul;69(7):1920-7. doi: 10.1093/jac/dku041. Epub 2014 Feb 26.2014
Lo GH, Lin CW, Perng DS, Chang CY, Lee CT, Hsu CY, Wang HM, Lin HC.A retrospective comparative study of histoacryl injection and banding ligation in the treatment of acute type 1 gastric variceal hemorrhage.Scand J Gastroenterol. 2013 Oct;48(10):1198-204. doi: 10.3109/00365521.2013.832792.2013
Lin CW, Lin CC, Mo LR, Chang CY, Perng DS, Hsu CC, Lo GH, Chen YS, Yen YC, Hu JT, Yu ML, Lee PH, Lin JT, Yang SS.Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.J Hepatol. 2013 Apr;58(4):730-5. doi: 10.1016/j.jhep.2012.11.045. Epub 2012 Dec 6.2013
Lo GH, Perng DS, Chang CY, Tai CM, Wang HM, Lin HC.A Controlled Trial of Ligation Plus Vasoconstrictor Versus Proton Pump Inhibitor in the Control of Acute Esophageal Variceal Bleeding.J Gastroenterol Hepatol. 2013 Apr;28(4):684-9. doi: 10.1111/jgh.12107.2013
Lo GH.The role of imaging techniques in clinical decision making for the management of hepatocellular carcinoma.Hepatology. 2012 Jan 30. doi: 10.1002/hep.25618. [Epub ahead of print]2012
Hsu YC, Mo LR, Chang CY, Perng DS, Tseng CH, Lo GH, Tai CM, Lin CW, Hsu CC, Hsu CY, Huang SC, Lin JT.Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation.Antivir Ther. 2012;17(4):605-12. doi: 10.3851/IMP2027. Epub 2011 Dec 20.2012
Wang HM, Lo GH, Chen WC, Hsu PI, Yu HC, Lin CK, Chan HH, Tsai WL, Tsay FW, Liu TP, Wang EM, Lai KH.Efficacy of transient elastography in screening for large esophageal varices in patients with suspicious or proven liver cirrhosisJ Dig Dis. 2012 Aug;13(8):430-8. doi: 10.1111/j.1751-2980.2012.00603.x.2012
Yi-Shin Huang, Chen-Yi Wu, Ting-Tsung Chang, Cheng-Yuan Peng, Gin-Ho Lo, Chao-Wei Hsu, Chi-Tan Hu, Yi-Hsiang Huang.Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.Liver Int. 2021 Jun 21. doi: 10.1111/liv.14990. Epub ahead of print.2012
Lo GH, Chen WC, Wang HM, Yu HC.Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.J Gastroenterol Hepatol. 2012 Nov;27(11):1681-7. doi: 10.1111/j.1440-1746.2012.07244.x.2012
Lo GHEffects of beta-blockers on survival for patients with cirrhosis and refractory ascites.Hepatology. 2011 Mar;53(3):1068-9. doi: 10.1002/hep.23986. Epub 2010 Dec 22.2011
Lo GH.The ethics of placebo treatment for patients with acute exacerbation of chronic hepatitis B.Hepatology. 2011 Aug;54(2):740. doi: 10.1002/hep.24392.2011
Lo GH.The use of the Blatchford score and Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage.Gastrointest Endosc. 2011 Mar;73(3):643; author reply 643-4.2011
Lo GH.Updated management of hepatocellular carcinoma.Hepatology. 2011 Sep 2;54(3):1113. doi: 10.1002/hep.24378. Epub 2011 Jul 21.2011
Lo GH.The role of endoscopy in secondary prophylaxis of esophageal varices.Clin Liver Dis. 2010 May;14(2):307-23.2010
Lo GH, Chen WC, Wang HM, Lee CC.Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding.Hepatology. 2010 Jul;52(1):230-7.2010
Lo GH.Mechanism of portal hypertensive gastropathy: an unresolved issue.J Gastroenterol Hepatol. 2009 Sep;24(9):1482-3.2009
Lo GH, Chen WC, Chan HH, Tsai WL, Hsu PI, Lin CK, Chen TA, Lai KH.A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding.J Gastroenterol Hepatol. 2009 Jun;24(6):982-7.2009
Lo GH.Could we standardize the injection technique and regimen of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices?Gastrointest Endosc. 2009 Jul;70(1):192-3; author reply 193.2009
Lo GH.Is body mass index really the most important factor determining the healing of reflux esophagitis by esomeprazole?Am J Gastroenterol. 2009 Mar;104(3):787; author reply 787-8. Epub 2009 Feb 24.2009
Lo GH.Combination of endoscopic band ligation with terlipressin is better than that with octreotide in shortening hospital stay?Am J Gastroenterol. 2009 Nov;104(11):2855; author reply 2855-6.2009
Lo, GH , Chen, WC , Wang, HM , Lin, CK , Chan, HH, Tsai, WL, Cheng, LC , Yu, HC , Tsay, FWLow-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varicesGUT, 58 (9): 1275-1280 SEP 20092009
Lo GH.Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: really safe and effective?Hepatology. 2009 Sep;50(3):988; author reply 988-9.2009
Lo GH.The management of cirrhotic ascites.Hepatology. 2009 Oct;50(4):1320; author reply 1321.2009